metformin and gsk-2816126

metformin has been researched along with gsk-2816126 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kong, Y; Li, Z; Liu, J; Liu, X; Mao, F; Wang, R; Zhang, Y; Zhang, Z1

Other Studies

1 other study(ies) available for metformin and gsk-2816126

ArticleYear
Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:12

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Metformin; Mice; MicroRNAs; Promoter Regions, Genetic; Prostatic Neoplasms; Pyridones; Receptors, Androgen; Transcriptional Activation; Xenograft Model Antitumor Assays

2020